Ameren Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ameren Corporation on October 8, 2010. The report details corporate governance actions taken by the Board of Directors during a meeting held on that date.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on amendments to the company's By-Laws and does not contain financial performance data.
Material Changes
The Board of Directors amended Article IV of Ameren's By-Laws regarding indemnification and advancement of expenses. Key changes include:
- Scope of Indemnitees: Excluded "agents" of Ameren and employees/agents of other entities serving at Ameren's request from the class of indemnitees.
- Definition of Service: Defined "serving at the request of the Company" as requiring express approval by the Nominating and Corporate Governance Committee or inclusion on an annually reviewed list of non-affiliated organizations.
- Payment Hierarchy: Established that indemnification for service at another entity is secondary to payments from that other entity.
- Mandatory Advancement: Made advancement of expenses mandatory for directors and officers upon an undertaking to repay, removing previous Board discretion.
- Liability Cap: Limited maximum liability for indemnification and expense advancement for persons serving at the request of the Company to $25 million, unless expressly approved otherwise by the Board.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. The primary risk addressed is the limitation of the company's financial exposure related to indemnification obligations, specifically capping liability at $25 million for external service roles.
Key Facts for Investor Verification
- Effective date of By-Law amendments: October 8, 2010.
- New maximum liability cap for indemnification of persons serving at the request of the Company: $25 million.
- Expense advancement is now mandatory for directors and officers upon undertaking to repay, rather than discretionary.
- Indemnification no longer covers "agents" of Ameren.